Rezolute (RZLT) Debt Ratio (2011 - 2021)

Rezolute's (RZLT) quarterly Debt Ratio came in at 0.05 in Q1 2021, up 385291.76% quarter-over-quarter from 0.0 in Q4 2017.

Rezolute (RZLT) Debt Ratio (2011 - 2021) Analysis & Trends

Rezolute has disclosed Debt Ratio across 7 years of filings, most recently posting 0.05 for Q1 2021.

Debt Ratio for Q1 2021 came in at 0.05, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was 0.05 (changed N/A YoY), and the FY2017 annual result was 0.0, down 94.95% from the prior year.
Debt Ratio came in at 0.05 for Q1 2021 at Rezolute, up from 0.0 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.05 in Q1 2021 to a low of 0.0 in Q4 2017.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	0.18
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Rezolute	520.13 Mn	520.13 Mn	-	-

Historic Data

Download Data

Date	Value
Mar 31, 2021	0.05
Dec 31, 2017	0.00
Sep 30, 2017	0.00
Jun 30, 2017	0.00
Mar 31, 2017	0.00
Dec 31, 2016	0.00
Sep 30, 2016	0.00
Jun 30, 2016	0.00
Mar 31, 2016	0.00
Dec 31, 2015	0.00
Sep 30, 2015	0.00
Jun 30, 2015	0.00
Dec 31, 2014	0.10
Sep 30, 2014	0.06
Jun 30, 2014	0.00
Mar 31, 2014	0.18
Dec 31, 2013	0.50
Sep 30, 2013	1.10
Jun 30, 2013	0.14
Mar 31, 2013	0.33